• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Benson Hill Announces Third Quarter 2023 Financial Results, Improves 2023 Outlook, and Pays Down Debt

    11/9/23 7:00:00 AM ET
    $BHIL
    Packaged Foods
    Consumer Staples
    Get the next $BHIL alert in real time by email
    • Reported revenues decreased 8 percent year-over-year to approximately $113.1 million. Proprietary revenues increased by 27 percent year-over-year.
    • Reported gross profit was $4.1 million (gross loss of $0.2 million when excluding an approximate $4.3 million impact from open mark-to-market timing differences).
    • The Company ended the third quarter with $86.2 million of cash, restricted cash, and marketable securities.
    • Management improves its 2023 financial guidance.
    • The Company expects to pay down approximately 50 percent of the senior convertible debt in November.

    Benson Hill, Inc. (NYSE:BHIL, the "Company" or "Benson Hill"))), a food tech company unlocking the natural genetic diversity of plants, today announced operating and financial results for the quarter ended September 30, 2023.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231109972823/en/

    Benson Hill Announces Third Quarter 2023 Financial Results, Improves 2023 Outlook, and Pays Down Debt (Graphic: Business Wire)

    Benson Hill Announces Third Quarter 2023 Financial Results, Improves 2023 Outlook, and Pays Down Debt (Graphic: Business Wire)

    "Our team effectively managed a challenging third quarter, addressing some softness in soy crush margins and reduced demand for proprietary products because of market headwinds," said Deanie Elsner, Chief Executive Officer of Benson Hill. "The combination of the sale of certain non-core licensing technologies and higher-than-planned soy white flake ingredient sales expected in the fourth quarter positions us to end 2023 consistent with our prior guidance for gross profit. We expect these market challenges to persist, further supporting our decision to accelerate the shift to an asset-light business model designed to serve broadacre animal feed markets with our seed innovations enabled through the CropOS® platform."

    Third Quarter Results Compared to the Same Period of 2022

    The following financial results exclude the completed divestiture of the Fresh business on June 30, 2023. The impact of open mark-to-market timing differences on the statement of operations and reconciliation of non-GAAP financial measures can be found in the accompanying financial tables.

    • Reported revenues were $113.1 million, a decrease of $9.2 million, or 7.5 percent, driven by a 17 percent decline in non-proprietary revenues due to record-level crush margins for soy and yellow pea in the third quarter of last year. Proprietary revenues were $33.1 million, a 27.2 percent increase, driven by greater availability of products compared to the prior year and the sale of proprietary soybeans into the commodity market. Reported revenues included an unfavorable $0.1 million impact from open mark-to-market timing differences.
    • Gross profit was $4.1 million, a decrease of $1.8 million. Excluding a favorable impact of $4.3 million from open mark-to-market timing differences, gross profit decreased by $4.7 million to a loss of $0.2 million due to the sale of proprietary products into the commodity markets at unfavorable margins and non-recurring factors affecting the supply chain, including logistics and unscheduled maintenance costs at our processing facilities.
    • Operating expenses were $28.4 million, a decrease of $2 million. The decrease was driven by the Liquidity Improvement Plan actions to deliver an expected $15 million run rate reduction in 2023 partially offset by $2.5 million of non-recurring expenses. Excluding the non-recurring items, operating expenses declined by approximately 14.7 percent to $25.9 million.
      • Selling, general, and administrative expenses were $17.9 million, a decrease of $1 million or 5.5 percent inclusive of non-recurring costs.
      • R&D expenses were $10.5 million, a decrease of $0.9 million or 8 percent.
    • Inclusive of open mark-to-market timing differences, net loss from continuing operations, net of income taxes, was $19.2 million, a decrease in reported loss of $7.2 million. Adjusted EBITDA was a loss of $14.2 million compared to a loss of $14.7 million in the prior year. Excluding the impact of open mark-to-market timing differences, the Adjusted EBITDA loss in the quarter was $18.5 million compared to a loss of $16.1 million for the same period last year.
    • Cash, restricted cash, and marketable securities of $86.2 million were on hand as of September 30, 2023.

    First Nine-Months Results Compared to the Same Period of 2022

    The following financial results exclude the completed divestiture of the Fresh business on June 30, 2023. The impact of open mark-to-market timing differences on the statement of operations and reconciliation of non-GAAP financial measures can be found in the accompanying financial tables.

    • Reported revenues were $356.7 million, an increase of $74.7 million, or 26.5 percent. Proprietary revenues were $77 million, an increase of 47.3 percent, driven by proprietary product sales into the aquaculture market and some limited soybean sales into the commodity markets. Reported revenues included a $6.3 million gain from open mark-to-market timing differences.
    • Gross profit was $16.6 million, an increase in profitability of $13.9 million, and includes a $6.4 million gain related to open mark-to-market timing differences. Overall profitability increased in dollar and margin percentage terms due to the combination of partnership and licensing agreements and improved operating results compared to start-up costs incurred in the prior year.
    • Operating expenses were $97.6 million, an increase of $2.4 million, or 2.5 percent, which include approximately $17.3 million of non-recurring costs, including a $19.2 million impairment of the carrying value of goodwill. Excluding these non-recurring items, operating expenses declined by 15.6 percent to $80.3 million due to cost reductions realized through the Company's Liquidity Improvement Plan.
    • Inclusive of the mark-to-market timing differences and goodwill impairment, the reported net loss from continuing operations, net of income taxes, was $73.2 million compared to a net loss of $68.9 million. Adjusted EBITDA was a loss of $41 million compared to a loss of $59.8 million.

    2023 Outlook

    Excludes the Fresh business which was divested on June 30, 2023.

    Management improved its guidance for 2023, driven by expectations for improved performance in the fourth quarter and continued benefits from the Liquidity Improvement Plan.

     

    2023 Guidance1

    $ USD Millions

    November 9

    August 9

    Consolidated revenues

    $440 - $450

    $390 - $430

    Proprietary revenues

    $100 - $110

    $100 - $110

    Gross profit

    $20 - $25

    $20 - $25

    Operating expenses

    $122 - $127

    $122 - $127

    Operating expenses, as adjusted2

    $101 - $106

    $110 - $115

    Net loss from continuing operations, net of income taxes

    $(100) - $(105)

    $(127) - $(137)

    Adjusted EBITDA2

    $(50) - $(55)

    $(53) - $(58)

    Capital expenditures

    $10 - $15

    $15 - $20

    Free cash flow2

    $(102) - $(107)

    $(110) - $(118)

    1 Categories such as income tax expense (benefit) and changes in fair value of warrants and conversion option, stock-based compensation and significant non-recurring items may impact the actual full-year non-GAAP reconciliation for both Adjusted EBITDA and Free Cash Flow. These amounts cannot be estimated at this time.

    2 Reconciliation of non-GAAP financial measures can be found in the accompanying financial tables.

    Webcast

    Management will hold an earnings conference call webcast at 8:30 a.m. ET today. The link to participate is available on the Investor Relations page of the Company's website.

    About Benson Hill

    Benson Hill moves food forward with the CropOS® platform, a cutting-edge food innovation engine that combines data science and machine learning with biology and genetics. Benson Hill empowers innovators to unlock nature's genetic diversity from plant to plate, with the purpose of creating nutritious, great-tasting food and ingredient options that are both widely accessible and sustainable. More information can be found at bensonhill.com or on X, formerly known as Twitter at @bensonhillinc.

    Use of Non-GAAP Financial Measures

    In this press release, the Company includes references to non-GAAP performance measures. The Company uses these non-GAAP financial measures to facilitate management's financial and operational decision-making, including evaluation of the Company's historical operating results. The Company's management believes these non-GAAP measures are useful in evaluating the Company's operating performance and are similar measures reported by publicly listed U.S. competitors, and regularly used by securities analysts, institutional investors, and other interested parties in analyzing operating performance and prospects. These non-GAAP financial measures reflect an additional way of viewing aspects of the Company's operations that, when viewed with GAAP results and the reconciliations to corresponding GAAP financial measures, may provide a more complete understanding of factors and trends affecting the Company's business. By referencing these non-GAAP measures, the Company's management intends to provide investors with a meaningful, consistent comparison of the Company's performance for the periods presented. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, financial information prepared in accordance with GAAP. The Company's definition of these non-GAAP measures may differ from similarly titled measures of performance used by other companies in other industries or within the same industry. In addition, the Company has and may in the future modify how it calculates non-GAAP performance measures. Because non-GAAP financial measures exclude the effect of items that will increase or decrease the Company's reported results of operations, management strongly encourages investors to review the Company's condensed consolidated financial statements and publicly filed reports in their entirety. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the tables accompanying this press release.

    Cautionary Note Regarding Forward-Looking Statements

    Certain statements in this press release may be considered "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or the Company's future financial or operating performance and may be identified by words such as "may," "should," "expect," "intend," "will," "estimate," "anticipate," "believe," "predict," or similar words, as well as the negative of such statements. These forward-looking statements are based upon assumptions made by the Company as of the date hereof and are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements include, among other things, statements regarding the Company's current guidance regarding certain expected 2023 financial and operating results, including guidance regarding consolidated, proprietary and non-proprietary revenues, consolidated gross profit, net loss from continuing operations, Adjusted EBITDA, run rate cash savings, operating expenses and operating expenses adjustments, and free cash flow; statements regarding the Company's current expectations and assumptions regarding the industries and markets in which it operates, including its transition to an asset-light business model to serve broadacre animal feed markets; macro-economic trends, including regarding commodity and proprietary markets and inflationary pressures; projections of market opportunity; statements regarding asset sales; statements regarding the Company's Liquidity Improvement Plan and other cost-saving measures, actions to implement such plan, and the anticipated benefits of and timeline to implement such plans; expectations regarding revenue and gross profit mix; the Company's ability to identify and evaluate its strategic alternatives and effect potential strategic opportunities in ways that maximize shareholder value; expectations regarding the Company's ability to continue as a going concern; statements regarding the execution of the Company's business plan, the strategic review of the Company's business, and the Company's executive leadership transition; expectations regarding future costs and uses of free cash flow; expectations regarding the unwinding of mark-to-market timing differences and the Company's assessment of its futures contracts; any financial or other information based upon or otherwise incorporating judgments or estimates relating to future performance, events or expectations; expectations regarding the Company's hedging and other risk management strategies, including expectations about future sales and purchases that relate to the Company's mark-to-market adjustments and the fair valuation of futures contracts; the Company's strategies, positioning, resources, capabilities, and expectations for future performance; estimates and forecasts of financial and other performance metrics; the Company's outlook and financial and other guidance. Factors that may cause actual results to differ materially from current expectations and guidance include, but are not limited to: risks associated with the Company's Liquidity Improvement Plan and other cost saving measures, including potentially adverse impacts on the Company's business and prospects even if such plans are successful; the risk that the Company's actions relating to its Liquidity Improvement Plan and other cost saving measures may be insufficient to achieve the objectives of such plans; liquidity and other risks relating to the Company's ability to continue as a going concern; the risk that the Company may fail to achieve its guidance; risks associated with the Company's ability to grow and achieve growth profitably, including continued access to the capital resources necessary for growth; risks relating to the Company's plans to sell certain assets; the risk that the Company will be unable to renegotiate or retire any of its existing debt on favorable terms, or at all; risks relating to the failure to realize the anticipated benefits of the Company's shelf registration statement, including its at-the-market facility, or otherwise failing to raise equity or other capital to supplement its cash needs; risks associated with the Company's execution of its executive leadership transition, including, among others, risks relating to maintaining key employee, customer, partner and supplier relationships; risks relating to the Company's hedging and other risk management strategies, including expectations about future sales and purchases that relate to the Company's mark-to-market adjustments and the fair valuation of futures contracts; the risk that the Company will not realize the anticipated benefits of the divestiture of the Fresh business; risks associated with managing capital resources; risks associated with maintaining relationships with customers and suppliers and developing and maintaining partnering and licensing relationships; risks associated with changing industry conditions and consumer preferences; risks associated with the Company's ability to generally execute on its business strategy, including its transition to an asset-light business model to serve broadacre animal feed markets; risks associated with the effects of global and regional economic, agricultural, financial and commodities market, political, social and health conditions; the effectiveness of the Company's risk management strategies; and other risks and uncertainties set forth in the sections entitled "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in our filings with the SEC, which are available on the SEC's website at www.sec.gov. Forward-looking statements are also subject to the risks and other issues described above under "Use of Non-GAAP Financial Measures," which could cause actual results to differ materially from current expectations included in the Company's forward-looking statements included in this press release. Nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved, including without limitation, any expectations about our operational and financial performance or achievements. There may be additional risks about which the Company is presently unaware or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Company expressly disclaims any duty to update these forward-looking statements, except as otherwise required by law.

    Benson Hill, Inc.

    Material Items Included in Consolidated Revenues and Cost of Sales

    (In Thousands)

    Currently, the Company does not seek cash flow hedge accounting treatment for its derivative financial instruments; thus changes in fair value are reflected in current earnings.

    Mark-to-market timing difference comprises the estimated net temporary impact resulting from unrealized period-end gains/losses associated with the fair valuation of futures contracts associated with the Company's committed future operating capacity. These mark-to-market timing differences are not indicative of the Company's operating performance.

    The table below summarizes the pre-tax gains and losses related to derivatives and contract assets and liabilities:

     

    Nine Months Ended September 30, 2023

     

     

     

    Open Mark-to-Market Timing Differences

    In Thousands

    YTD Reported

     

    Q1 Impact

     

    Q2 Impact

     

    Q3 Impact

     

    YTD Impact

     

    YTD Excluding

    Revenues

    $

    356,747

     

     

    $

    6,725

     

    $

    (275

    )

     

    $

    (131

    )

     

    $

    6,319

     

    $

    350,428

     

    Gross profit

    $

    16,630

     

     

    $

    5,229

     

    $

    (3,110

    )

     

    $

    4,298

     

     

    $

    6,417

     

    $

    10,213

     

    Total operating expenses

    $

    97,598

     

     

    $

    —

     

    $

    —

     

     

    $

    —

     

     

    $

    —

     

    $

    97,598

     

    Net loss from continuing operations, net of income taxes

    $

    (73,203

    )

     

    $

    5,229

     

    $

    (3,110

    )

     

    $

    4,298

     

     

    $

    6,417

     

    $

    (79,620

    )

    Adjusted EBITDA

    $

    (40,981

    )

     

    $

    5,229

     

    $

    (3,110

    )

     

    $

    4,298

     

     

    $

    6,417

     

    $

    (47,398

    )

    • See Adjusted EBITDA reconciliation in the accompanying financial tables.

    Benson Hill, Inc.

    Condensed Consolidated Balance Sheets (Unaudited)

    (In Thousands, Except Per Share Data)

    ​

    September 30,

    2023

     

    December 31,

    2022

    Assets

    ​

    ​

    ​

    Current assets:

    ​

    ​

    ​

    Cash and cash equivalents

    $

    12,041

     

     

    $

    25,053

     

    Restricted cash

     

    20,438

     

     

     

    17,912

     

    Marketable securities

     

    53,524

     

     

     

    132,121

     

    Accounts receivable, net

     

    37,553

     

     

     

    28,591

     

    Inventories, net

     

    30,419

     

     

     

    62,110

     

    Prepaid expenses and other current assets

     

    13,883

     

     

     

    11,434

     

    Current assets of discontinued operations

     

    555

     

     

     

    23,507

     

    Total current assets

     

    168,413

     

     

     

    300,728

     

    Property and equipment, net

     

    99,628

     

     

     

    99,759

     

    Finance lease right-of-use assets, net

     

    61,511

     

     

     

    66,533

     

    Operating lease right-of-use assets

     

    5,542

     

     

     

    1,660

     

    Goodwill and intangible assets, net

     

    7,587

     

     

     

    27,377

     

    Other assets

     

    9,838

     

     

     

    4,863

     

    Total assets

    $

    352,519

     

     

    $

    500,920

     

     

     

     

     

    Liabilities and stockholders' equity

    ​

    ​

    ​

    Current liabilities:

    ​

    ​

    ​

    Accounts payable

    $

    14,134

     

     

    $

    36,717

     

    Finance lease liabilities, current portion

     

    3,935

     

     

     

    3,318

     

    Operating lease liabilities, current portion

     

    1,456

     

     

     

    364

     

    Long-term debt, current portion

     

    35,581

     

     

     

    2,242

     

    Accrued expenses and other current liabilities

     

    18,639

     

     

     

    33,435

     

    Current liabilities of discontinued operations

     

    871

     

     

     

    16,441

     

    Total current liabilities

     

    74,616

     

     

     

    92,517

     

    Long-term debt, less current portion

     

    73,596

     

     

     

    103,991

     

    Finance lease liabilities, less current portion

     

    75,399

     

     

     

    76,431

     

    Operating lease liabilities, less current portion

     

    6,333

     

     

     

    1,291

     

    Warrant liabilities

     

    1,694

     

     

     

    24,285

     

    Conversion option liabilities

     

    21

     

     

     

    8,091

     

    Deferred income taxes

     

    155

     

     

     

    283

     

    Other non-current liabilities

     

    231

     

     

     

    129

     

    Total liabilities

     

    232,045

     

     

     

    307,018

     

    Stockholders' equity:

    ​

     

    ​

    Common stock, $0.0001 par value, 440,000 and 440,000 shares authorized, 207,981 and 206,668 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively

     

    21

     

     

     

    21

     

    Additional paid-in capital

     

    609,554

     

     

     

    609,450

     

    Accumulated deficit

     

    (485,939

    )

     

     

    (408,474

    )

    Accumulated other comprehensive loss

     

    (3,162

    )

     

     

    (7,095

    )

    Total stockholders' equity

     

    120,474

     

     

     

    193,902

     

    Total liabilities and stockholders' equity

    $

    352,519

     

     

    $

    500,920

     

    Benson Hill, Inc.

    Condensed Consolidated Statements of Operations (Unaudited)

    (In Thousands, Except Per Share Data)

    ​

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

    ​

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

    Revenues

    $

    113,066

     

     

    $

    122,296

     

     

    $

    356,747

     

     

    $

    282,053

     

    Cost of sales

     

    108,927

     

     

     

    116,365

     

     

     

    340,117

     

     

     

    279,315

     

    Gross profit (loss)

     

    4,139

     

     

     

    5,931

     

     

     

    16,630

     

     

     

    2,738

     

    Operating expenses:

    ​

     

    ​

     

    ​

     

    ​

    Research and development

     

    10,525

     

     

     

    11,438

     

     

     

    33,480

     

     

     

    35,739

     

    Selling, general and administrative expenses

     

    17,874

     

     

     

    18,912

     

     

     

    44,892

     

     

     

    59,448

     

    Impairment of goodwill

     

    —

     

     

     

    —

     

     

     

    19,226

     

     

     

    —

     

    Total operating expenses

     

    28,399

     

     

     

    30,350

     

     

     

    97,598

     

     

     

    95,187

     

    Loss from operations

     

    (24,260

    )

     

     

    (24,419

    )

     

     

    (80,968

    )

     

     

    (92,449

    )

    Other (income) expense:

    ​

     

    ​

     

    ​

     

    ​

    Interest expense, net

     

    7,179

     

     

     

    6,200

     

     

     

    20,425

     

     

     

    16,030

     

    Changes in fair value of warrants and conversion option

     

    (12,001

    )

     

     

    (4,036

    )

     

     

    (30,661

    )

     

     

    (41,676

    )

    Other expense, net

     

    (201

    )

     

     

    (181

    )

     

     

    2,588

     

     

     

    2,104

     

    Total other (income) expense, net

     

    (5,023

    )

     

     

    1,983

     

     

     

    (7,648

    )

     

     

    (23,542

    )

    Net loss from continuing operations before income taxes

     

    (19,237

    )

     

     

    (26,402

    )

     

     

    (73,320

    )

     

     

    (68,907

    )

    Income tax expense (benefit)

     

    6

     

     

     

    13

     

     

     

    (117

    )

     

     

    30

     

    Net loss from continuing operations, net of income taxes

     

    (19,243

    )

     

     

    (26,415

    )

     

     

    (73,203

    )

     

     

    (68,937

    )

    Net (loss) income from discontinued operations, net of tax

     

    1,673

     

     

     

    (3,754

    )

     

     

    (4,262

    )

     

     

    (5,362

    )

    Net loss attributable to common stockholders

    $

    (17,570

    )

     

    $

    (30,169

    )

     

    $

    (77,465

    )

     

    $

    (74,299

    )

     

     

     

     

     

     

     

     

    Net loss per common share:

     

     

     

     

     

     

     

    Basic and diluted net loss per common share from continuing operations

    $

    (0.10

    )

     

    $

    (0.14

    )

     

    $

    (0.39

    )

     

    $

    (0.39

    )

    Basic and diluted net loss per common share from discontinued operations

    $

    0.01

     

     

    $

    (0.02

    )

     

    $

    (0.02

    )

     

    $

    (0.03

    )

    Basic and diluted total net loss per common share

    $

    (0.09

    )

     

    $

    (0.16

    )

     

    $

    (0.41

    )

     

    $

    (0.42

    )

    Weighted average shares outstanding:

    ​

     

    ​

     

    ​

     

    ​

    Basic and diluted weighted average shares outstanding

     

    188,223

     

     

     

    186,097

     

     

     

    187,691

     

     

     

    177,539

     

    Benson Hill, Inc.

    Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

    (In Thousands)

    ​

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

    ​

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

    Net loss attributable to common stockholders

    $

    (17,570

    )

     

    $

    (30,169

    )

     

    $

    (77,465

    )

     

    $

    (74,299

    )

    Foreign currency:

    ​

     

    ​

     

    ​

     

    ​

    Comprehensive income (loss)

     

    —

     

     

     

    (1

    )

     

     

    —

     

     

     

    (46

    )

     

     

    —

     

     

     

    (1

    )

     

     

    —

     

     

     

    (46

    )

    Marketable securities:

    ​

     

    ​

     

    ​

     

    ​

    Comprehensive income (loss)

     

    395

     

     

     

    (1,759

    )

     

     

    875

     

     

     

    (9,918

    )

    Adjustment for net loss (income) realized in net loss

     

    14

     

     

     

    (97

    )

     

     

    3,058

     

     

     

    2,132

     

     

     

    409

     

     

     

    (1,856

    )

     

     

    3,933

     

     

     

    (7,786

    )

    Total other comprehensive income (loss)

     

    409

     

     

     

    (1,857

    )

     

     

    3,933

     

     

     

    (7,832

    )

    Total comprehensive loss

    $

    (17,161

    )

     

    $

    (32,026

    )

     

    $

    (73,532

    )

     

    $

    (82,131

    )

    Benson Hill, Inc.

    Condensed Consolidated Statements of Cash Flows (Unaudited)

    (In Thousands)

    ​

    Nine Months Ended September 30,

    ​

     

    2023

     

     

     

    2022

     

    Operating activities

     

     

     

    Net loss

    $

    (77,465

    )

     

    $

    (74,299

    )

    Adjustments to reconcile net loss to net cash used in operating activities:

     

     

     

    Depreciation and amortization

     

    16,056

     

     

     

    16,504

     

    Stock-based compensation expense

     

    (347

    )

     

     

    15,771

     

    Bad debt expense

     

    (263

    )

     

     

    724

     

    Changes in fair value of warrants and conversion option

     

    (30,661

    )

     

     

    (41,676

    )

    Accretion and amortization related to financing activities

     

    6,624

     

     

     

    8,481

     

    Realized losses on sale of marketable securities

     

    3,058

     

     

     

    2,132

     

    Impairment of goodwill

     

    19,226

     

     

     

    —

     

    Other

     

    1,815

     

     

     

    4,180

     

    Changes in operating assets and liabilities:

     

     

     

    Accounts receivable

     

    (3,073

    )

     

     

    (7,208

    )

    Inventories

     

    43,323

     

     

     

    6,441

     

    Other assets and other liabilities

     

    (4,170

    )

     

     

    8,052

     

    Accounts payable

     

    (32,306

    )

     

     

    (6,093

    )

    Accrued expenses

     

    (15,685

    )

     

     

    2,604

     

    Net cash used in operating activities

     

    (73,868

    )

     

     

    (64,387

    )

    Investing activities

     

     

     

    Purchases of marketable securities

     

    (87,619

    )

     

     

    (350,333

    )

    Proceeds from maturities of marketable securities

     

    66,193

     

     

     

    109,514

     

    Proceeds from sales of marketable securities

     

    99,838

     

     

     

    170,217

     

    Purchase of property and equipment

     

    (10,127

    )

     

     

    (11,835

    )

    Acquisition, net of cash acquired

     

    —

     

     

     

    (1,044

    )

    Proceeds from divestiture of discontinued operations

     

    2,378

     

     

     

    —

     

    Proceeds from an insurance claim from a prior business acquisition

     

    1,533

     

     

     

    —

     

    Other

     

    41

     

     

     

    —

     

    Net cash provided by (used in) investing activities

     

    72,237

     

     

     

    (83,481

    )

    Financing activities

     

     

     

    Contributions from PIPE Investment, net of transaction costs $3,761 in 2022

     

    —

     

     

     

    80,825

     

    Repayments of long-term debt

     

    (4,874

    )

     

     

    (6,736

    )

    Proceeds from issuance of long-term debt

     

    —

     

     

     

    24,078

     

    Payments of debt issuance costs

     

    (2,000

    )

     

     

    (38

    )

    Borrowing under revolving line of credit

     

    —

     

     

     

    18,970

     

    Repayments under revolving line of credit

     

    —

     

     

     

    (19,017

    )

    Payments of finance lease obligations

     

    (2,428

    )

     

     

    (1,103

    )

    Proceeds from exercise of stock awards, net of withholding taxes

     

    249

     

     

     

    1,950

     

    Net cash (used in)/provided by financing activities

     

    (9,053

    )

     

     

    98,929

     

    Effect of exchange rate changes on cash

     

    —

     

     

     

    (46

    )

    Net decrease in cash and cash equivalents

     

    (10,684

    )

     

     

    (48,985

    )

    Cash, cash equivalents and restricted cash, beginning of period

     

    43,321

     

     

     

    78,963

     

    Cash, cash equivalents and restricted cash, end of period

    $

    32,637

     

     

    $

    29,978

     

    Supplemental disclosure of cash flow information

     

    Cash paid for taxes

    $

    35

    $

    1

     

    Cash paid for interest

    $

    14,523

    $

    9,864

     

    Supplemental disclosure of non-cash activities

     

    PIPE Investment issuance costs included in accrued expenses and other current liabilities

     

    Purchases of property and equipment included in liabilities

    $

    125

    $

    2,710

     

    Financing leases commencing in the period

    $

    —

    $

    806

     

    Benson Hill, Inc.

    Non-GAAP Reconciliation

    (In Thousands)

    This press release contains financial measures not derived in accordance with generally accepted accounting principles ("GAAP"). Reconciliations to the most comparable GAAP measures are provided below. The Company defines Adjusted EBITDA as net loss from continuing operations excluding income taxes, interest, depreciation, amortization, stock-based compensation, changes in fair value of warrants and conversion options, realized (gains) losses on marketable securities, goodwill, and long-lived asset impairment, restructuring-related costs (including severance costs) and the impact of significant non-recurring items. The Company defines free cash flow as net cash used in (provided by) operating activities minus capital expenditures. The Company defines operating expenses, as adjusted as operating expenses excluding expenses incurred in relation to the transition to an asset-light business model and significant non-recurring items.

    Adjustments to reconcile net loss from our continuing operations to Adjusted EBITDA:

     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

     

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

    Net loss from continuing operations, net of income taxes

    $

    (19,243

    )

     

    $

    (26,415

    )

     

    $

    (73,203

    )

     

    $

    (68,937

    )

    Interest expense, net

     

    7,179

     

     

     

    6,200

     

     

     

    20,425

     

     

     

    16,030

     

    Income tax expense (benefit)

     

    6

     

     

     

    13

     

     

     

    (117

    )

     

     

    30

     

    Depreciation and amortization

     

    5,460

     

     

     

    5,052

     

     

     

    16,056

     

     

     

    14,992

     

    Stock-based compensation

     

    867

     

     

     

    4,412

     

     

     

    (392

    )

     

     

    15,771

     

    Changes in fair value of warrants and conversion

     

    (12,001

    )

     

     

    (4,036

    )

     

     

    (30,661

    )

     

     

    (41,676

    )

    Impairment of goodwill

     

    —

     

     

     

    —

     

     

     

    19,226

     

     

     

    —

     

    Severance

     

    386

     

     

     

    185

     

     

     

    1,624

     

     

     

    474

     

    Other

     

    3,187

     

     

     

    (95

    )

     

     

    6,061

     

     

     

    3,489

     

    Total Adjusted EBITDA

    $

    (14,159

    )

     

    $

    (14,684

    )

     

    $

    (40,981

    )

     

    $

    (59,827

    )

    Adjustments to reconcile estimated 2023 net loss from continuing operations to the estimated Adjusted EBITDA:

     

    2023 Estimate*

    Consolidated net loss from continuing operations

    $

    (100,000

    )

    to

    $

    (105,000

    )

    Interest expense, net

     

    36,000

     

    to

     

    38,000

     

    Depreciation and amortization

     

    21,000

     

    to

     

    25,000

     

    Stock-based compensation

     

    3,000

     

    to

     

    5,000

     

    Change in fair value of warrants and conversion option

     

    (31,000

    )

    to

     

    (31,000

    )

    Impairment of goodwill

     

    19,000

     

    to

     

    19,000

     

    Severance

     

    2,000

     

     

     

    4,000

     

    Other

     

    —

     

     

     

    (10,000

    )

    Total Adjusted EBITDA

    $

    (50,000

    )

    to

    $

    (55,000

    )

    Adjustments to reconcile the estimated 2023 free cash flow:

     

    2023 Estimate*

    Consolidated net loss from continuing operations

    $

    (100,000

    )

    to

    $

    (105,000

    )

    Depreciation and amortization

     

    21,000

     

    to

     

    25,000

     

    Stock-based compensation

     

    3,000

     

    to

     

    5,000

     

    Impairment of goodwill

     

    19,000

     

    to

     

    19,000

     

    Change in fair value of warrants and conversion option

     

    (31,000

    )

     

     

    (31,000

    )

    Changes in working capital

     

    (1,000

    )

    to

     

    (5,000

    )

    Other

     

    (3,000

    )

    to

     

    —

     

    Net Cash Used in Operating Activities

    $

    (92,000

    )

    to

    $

    (92,000

    )

    Payments for the acquisition of property and equipment

     

    (10,000

    )

    to

     

    (15,000

    )

    Free Cash Flow

    $

    (102,000

    )

    to

    $

    (107,000

    )

    * Categories such as income tax expense (benefit) and changes in fair value of warrants and conversion option, stock-based compensation and significant non-recurring items may impact the actual full-year non-GAAP reconciliation for both Adjusted EBITDA and Free Cash Flow. These amounts cannot be estimated at this time.

    Adjustments to reconcile operating expenses to operating expenses, as adjusted:

     

    2023 Estimate

    Operating expenses

    $

    122,000

     

    to

    $

    127,000

     

    Non-cash stock-based compensation

     

    8,000

     

    to

     

    8,000

     

    Goodwill impairment

     

    (19,000

    )

    to

     

    (19,000

    )

    Exit costs related to divestiture of Seymour facility

     

    (4,000

    )

    to

     

    (4,000

    )

    Advisory fees related to business evolution

     

    (4,000

    )

    to

     

    (4,000

    )

    Severance and other

     

    (2,000

    )

    to

     

    (2,000

    )

    Operating expenses, as adjusted

    $

    101,000

     

    to

    $

    106,000

     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231109972823/en/

    Get the next $BHIL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BHIL

    DatePrice TargetRatingAnalyst
    8/10/2023Outperform → Perform
    Oppenheimer
    10/4/2022$7.00Buy
    Lake Street
    3/25/2022$9.00Buy
    ROTH Capital
    12/9/2021$9.00Outperform
    Oppenheimer
    11/23/2021$9.00Neutral
    Goldman Sachs
    10/25/2021$10.00Overweight
    Barclays
    More analyst ratings

    $BHIL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Benson Hill Receives Court Approval of First-Day Motions to Support Ongoing Operations During Chapter 11 Process

      Operations will continue as normal for the Company during the transitional period. Employee wages and benefits will be paid following DIP financing approval. Court authorizes vendor payments and critical operational support. Benson Hill, Inc. (NASDAQ:BHIL, "Benson Hill")), a seed innovation company, today announced that the U.S. Bankruptcy Court for the District of Delaware has approved the Company's initial "first-day" motions following its voluntary filing for relief under Chapter 11 of the U.S. Bankruptcy Code on March 20, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250325440772/en/BHIL, "Benson Hill")), a seed

      3/25/25 4:45:00 PM ET
      $BHIL
      Packaged Foods
      Consumer Staples
    • Benson Hill Files Voluntary Chapter 11 Petitions

      Debtor-in-Possession Financing Secured to Support Ongoing Operations and Chapter 11 Process. Company Filed a Variety of First-Day Motions, Subject to Court Approval. Benson Hill, Inc. (NASDAQ:BHIL, "Benson Hill")), a seed innovation company, today announced that it and its subsidiaries (collectively, the "Company") filed voluntary petitions for relief under Chapter 11 of Title 11 of the U.S. Bankruptcy Code ("Chapter 11") in the United States Bankruptcy Court for the District of Delaware (the "Court"). The Company further disclosed that it intends to pursue a sale of its business under Section 363 of the Bankruptcy Code, including a sale of all or a portion of the Company's assets, whi

      3/20/25 9:00:00 AM ET
      $BHIL
      Packaged Foods
      Consumer Staples
    • Benson Hill Ultra-High Protein Soybean Meal Validated in Tyson Foods Feeding Trial

      Latest collaboration represents the third major poultry feeding trial using the Company's Ultra-High Protein, Low-Oligosaccharide (UHP-LO) soybean meal in poultry diets. Proprietary soy quality traits translate into higher nutritional efficiency and lower feed costs for poultry producers and integrators. Benson Hill, Inc. (NASDAQ:BHIL, the "Company" or "Benson Hill")), a seed innovation company, today announced positive results from a controlled broiler feeding trial conducted with Tyson Foods. Study findings, consistent with those released in May 2024, demonstrate how Benson Hill's Ultra-High Protein, Low Oligosaccharide (UHP-LO) soybean meal offers a high-performance, cost-effectiv

      1/30/25 3:00:00 PM ET
      $BHIL
      Packaged Foods
      Consumer Staples

    $BHIL
    SEC Filings

    See more
    • Benson Hill Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Creation of a Direct Financial Obligation, Costs Associated with Exit or Disposal Activities, Leadership Update, Material Impairments, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Benson Hill, Inc. (0001830210) (Filer)

      3/25/25 4:48:15 PM ET
      $BHIL
      Packaged Foods
      Consumer Staples
    • SEC Form NT 10-K filed by Benson Hill Inc.

      NT 10-K - Benson Hill, Inc. (0001830210) (Filer)

      3/18/25 5:23:20 PM ET
      $BHIL
      Packaged Foods
      Consumer Staples
    • SEC Form SCHEDULE 13G filed by Benson Hill Inc.

      SCHEDULE 13G - Benson Hill, Inc. (0001830210) (Subject)

      2/14/25 9:43:42 PM ET
      $BHIL
      Packaged Foods
      Consumer Staples

    $BHIL
    Leadership Updates

    Live Leadership Updates

    See more
    • Benson Hill Announces Second Quarter Financial Results

      Second quarter revenues of approximately $33.8 million, an increase compared to $23.5 million in the same period of 2023, reflect the Company's ongoing transition to an asset-light business model. Net loss from continuing operations, net of income taxes, was $18 million in the quarter, an improvement of $18.5 million in reported loss from the same period of the prior year. Adjusted EBITDA was a loss of $12.4 million, compared to a loss of $15.2 million in the same period of 2023, due primarily to expense reductions. Free cash flow loss in the first half of 2024 was $31.8 million, which was approximately 50 percent of the free cash flow loss in the first half of 2023. The Company e

      8/8/24 7:00:00 AM ET
      $BHIL
      Packaged Foods
      Consumer Staples
    • Benson Hill Transitions to Licensing Model, Improves Financial Profile in First Quarter

      Reported revenues for the quarter were approximately $21.1 million, excluding results of the divested processing assets, as the business transitions to an asset-light licensing model. Business transition execution led to improved gross profit and reduced operating expenses, with the Company delivering gross profit of $5.2 million and operating expenses of $21.8 million, compared to gross profit of $4.6 million and operating expenses of $25.9 million in the prior year. Cash used in operating activities from continuing operations was $10.2 million, a $24.3 million reduction from $34.5 million used in the prior year. The Company ended the first quarter with $30.5 million of cash and mar

      5/9/24 7:01:00 AM ET
      $BHIL
      Packaged Foods
      Consumer Staples
    • Benson Hill Names Dan Cosgrove as Chief Administrative Officer and General Counsel

      Former CEO of Growers Edge begins in role May 10 Benson Hill, Inc. (NYSE:BHIL), an ag tech company unlocking the natural genetic diversity of plants, has named agriculture industry leader Dan Cosgrove as Chief Administrative Officer and General Counsel, effective May 10, 2024. He will assume responsibility for Benson Hill's day-to-day operations related to business development, compliance, and legal matters. Chief Legal Officer Yevgeny Fundler is leaving Benson Hill to pursue other opportunities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240509748763/en/Benson Hill Names Dan Cosgrove as Chief Administrative Officer and Ge

      5/9/24 7:00:00 AM ET
      $BHIL
      Packaged Foods
      Consumer Staples

    $BHIL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Benson Hill Inc.

      SC 13G/A - Benson Hill, Inc. (0001830210) (Subject)

      11/8/24 4:20:55 PM ET
      $BHIL
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form SC 13D/A filed by Benson Hill Inc.

      SC 13D/A - Benson Hill, Inc. (0001830210) (Subject)

      10/16/24 4:26:00 PM ET
      $BHIL
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form SC 13D/A filed by Benson Hill Inc.

      SC 13D/A - Benson Hill, Inc. (0001830210) (Subject)

      10/16/24 4:15:28 PM ET
      $BHIL
      Packaged Foods
      Consumer Staples

    $BHIL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Rohr Craig returned 2,211 shares to the company, decreasing direct ownership by 12% to 16,341 units (SEC Form 4)

      4 - Benson Hill, Inc. (0001830210) (Issuer)

      10/1/24 5:06:20 PM ET
      $BHIL
      Packaged Foods
      Consumer Staples
    • Large owner Chiu Rita Wing Nga disposed of 43,899 shares (SEC Form 4)

      4 - Benson Hill, Inc. (0001830210) (Issuer)

      9/30/24 4:27:27 PM ET
      $BHIL
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form 3 filed by new insider Cosgrove Daniel J

      3/A - Benson Hill, Inc. (0001830210) (Issuer)

      8/12/24 4:31:42 PM ET
      $BHIL
      Packaged Foods
      Consumer Staples

    $BHIL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Benson Hill downgraded by Oppenheimer

      Oppenheimer downgraded Benson Hill from Outperform to Perform

      8/10/23 8:04:54 AM ET
      $BHIL
      Packaged Foods
      Consumer Staples
    • Lake Street initiated coverage on Benson Hill with a new price target

      Lake Street initiated coverage of Benson Hill with a rating of Buy and set a new price target of $7.00

      10/4/22 8:56:41 AM ET
      $BHIL
      Packaged Foods
      Consumer Staples
    • ROTH Capital initiated coverage on Benson Hill with a new price target

      ROTH Capital initiated coverage of Benson Hill with a rating of Buy and set a new price target of $9.00

      3/25/22 9:27:05 AM ET
      $BHIL
      Packaged Foods
      Consumer Staples

    $BHIL
    Financials

    Live finance-specific insights

    See more
    • Benson Hill Announces Listing Transfer to The Nasdaq Stock Market LLC

      Benson Hill, Inc. (NYSE:BHIL, the "Company" or "Benson Hill"))), a seed innovation company, announced today that it will transfer its stock exchange listing to The Nasdaq Stock Market LLC ("Nasdaq") from the New York Stock Exchange, effective Aug. 23, 2024, after market close. The Company expects to begin trading as a Nasdaq-listed company on Aug. 26, 2024, and its common stock will continue to trade under the symbol "BHIL." "The transfer to Nasdaq will permit the Company to realize cost savings and facilitate the continued listing of our Common Stock on a national securities exchange," said Deanie Elsner, Chief Executive Officer of Benson Hill. About Benson Hill Benson Hill is a se

      8/13/24 4:30:00 PM ET
      $BHIL
      Packaged Foods
      Consumer Staples
    • Benson Hill Reports Solid Full-Year 2023 Financial Results, Strengthens Balance Sheet

      The Company fully retired its senior convertible debt in February 2024 after paying down approximately 50 percent in November 2023. The Company ended the year with $48.9 million in cash and marketable securities. Reported revenues increased 24 percent to $473.3 million. Reported gross profit increased $20.1 million to $23.6 million. Net loss from continuing operations, net of income taxes, was $111.3 million and $99.7 million for the years ended December 31, 2023, and 2022, respectively. Adjusted EBITDA loss improved more than 40 percent year-over-year. Management is delivering its cost-cutting goals under the expanded Liquidity Improvement Plan and accelerating progress tow

      3/14/24 7:00:00 AM ET
      $BHIL
      Packaged Foods
      Consumer Staples
    • Benson Hill Announces Date of Fourth Quarter and Full Year Earnings Release

      Benson Hill, Inc. (NYSE:BHIL, the "Company" or "Benson Hill"))), an ag tech company unlocking the natural genetic diversity of plants, announced today that it will release its financial results for the full year and fourth quarter ending Dec. 31, 2023, before the market opens on Thursday, March 14, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240207953208/en/Benson Hill (BHIL) announces full year and fourth quarter 2023 earnings date (Graphic: Business Wire) The Company will host a webcast to discuss the results at 8:30 a.m. Eastern Time, including a presentation by management followed by a Q&A session. The March 14 webc

      2/7/24 4:00:00 PM ET
      $BHIL
      Packaged Foods
      Consumer Staples